March 30 (Reuters) - IMV Inc IMV.TO :
* IMV INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL AND OPERATIONAL RESULTS
* IMV INC - HAVE DECIDED TO LAUNCH DEVELOPMENT OF A DPX-BASED VACCINE AGAINST COVID-19
* IMV - IN CONTEXT OF COVID-19 PANDEMIC, IMV EXPECTS TO REPORT PRELIMINARY TOPLINE CLINICAL RESULTS ON SEVERAL OF SOLID TUMOR INDICATIONS LATER IN 2020